Analysis of fluid{-}phase mediators

Kelly M.M., Keatings V., Leigh R., Peterson C., Shute J., Venge P., Djukanovic R.

Source: Eur Respir J 2002; 20: 24S-39S
Journal Issue: July 2002 - Suppl. 37

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kelly M.M., Keatings V., Leigh R., Peterson C., Shute J., Venge P., Djukanovic R.. Analysis of fluid{-}phase mediators. Eur Respir J 2002; 20: 24S-39S

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proinflammatory cytokine production during exercise: role of antioxidants and monocytes
Source: Eur Respir J 2002; 20: Suppl. 38, 288s
Year: 2002

Proteome profiling reveals candidate mediators of TGF-β-induced glucocorticoid resistance
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Analysis of oxymetazolines´ inflammation inhibiting and resolving properties in human neutrophils
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009


Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013

Airway fibroblasts phenotype markers after pro-inflammatory cytokines challenge
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009


Role of anti-inflammatory treatments in complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006


Study of influence of interleukin-1b on cytokines production in inflammatory sites
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007


Regulation of inflammation
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004

Aerobic training inhibits leukocytes production of oxidants, pro-inflammatory and pro-fibrotic factors reducing asthmatic phenotype
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012


Proinflammatory cytokines in induced sputum and COPD phenotype
Source: Annual Congress 2011 - COPD: human studies
Year: 2011

Activation of HIF-1 by mediators of inflammation
Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms
Year: 2007



Mouse pathway biology models: Investigating the biology of alternaria alternata induced lung inflammation in the mouse - Role of ILC2 and Th2 cytokines
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Proteomic profiling to define synergistic responses mediated by IL-17 and TNFa in the lungs
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018

Analysis of P2Y12 receptor responsiveness to cysteinyl leukotrienes
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011